Hirohito Umeno1, Masamitsu Hyodo2, Tomoyuki Haji3, Hirotaka Hara4, Mitsuyoshi Imaizumi5, Miyoko Ishige6, Masanobu Kumada7, Kiyoshi Makiyama8, Noriko Nishizawa9, Koichiro Saito10, Osamu Shiromoto11, Atsushi Suehiro12, Goro Takahashi13, Ichiro Tateya12, Koichi Tsunoda14, Akihiro Shiotani15, Koichi Omori12. 1. Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine, Japan. Electronic address: umeno2@med.kurume-u.ac.jp. 2. Department Otolaryngology, Kochi University School of Medicine, Japan. 3. Kurashiki Central Hospital, Japan. 4. Department of Otolaryngology, Kawasaki Medical School, Japan. 5. Department of Otolaryngology, School of Medicine, Fukushima Medical University, Japan. 6. Speech Pathology and Hearing Course, Department of Rehabilitation, Faculty of Medical Science and Welfare, Tohoku Bunka Gakuen University, Japan. 7. Kumada Clinic, Japan. 8. Department of Otorhinolaryngology-Head and Neck Surgery, Nihon University School of Medicine, Japan. 9. School of Rehabilitation Sciences, Health Sciences University of Hokkaido, Japan. 10. Kyorin University School of Medicine, Department of Otolaryngology-Head and Neck Surgery, Japan. 11. Department of Communication Sciences and Disorders, Faculty of Health and Welfare, Prefectural University of Hiroshima, Japan. 12. Department of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Japan. 13. Yamahoshi Ear, Nose, and Throat Clinic, Japan. 14. Department of Artificial Organs and Medical Creation, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Japan. 15. Department of Otolaryngology - Head and Neck Surgery, National Defense Medical College, Japan.
Abstract
OBJECTIVE: To develop a summary of the first version of the Clinical Practice Guideline of Voice Disorders for Diagnosis, Management, and Treatment in Japan by the Clinical Practice Guideline Committee of the Japan Society of Logopedics and Phoniatrics and The Japan Laryngological Association. The 2018 recommendations, based on a review of the scientific literature, are intended to serve as clinical practice guidelines for the diagnosis, management, and treatment of voice disorders in Japan. METHODS: A summary of the original version of the Clinical Practice Guideline of Voice Disorders for Diagnosis, Management, and Treatment in Japan was described. Recommendations for the diagnosis, management, and treatment of voice disorders were prepared. Twelve clinical questions (CQs) regarding the diagnosis, management, treatment, and effectiveness of therapy for voice disorders were also prepared. RESULTS: A summary of the first version of the clinical practice guidelines for the diagnosis, management, and therapy of voice disorders was prepared and is presented. Additionally, answers to the 12 CQs on the diagnosis, management, treatment, and effectiveness of voice disorder therapy were prepared, and include evidence-based recommendations. CONCLUSION: These guidelines present a summary of the standard approaches for the diagnosis and treatment of voice disorders and relevant CQs that consider the medical environments in Japan. We hope that the guidelines will assist physicians in clinical settings for patients with voice disorders.
OBJECTIVE: To develop a summary of the first version of the Clinical Practice Guideline of Voice Disorders for Diagnosis, Management, and Treatment in Japan by the Clinical Practice Guideline Committee of the Japan Society of Logopedics and Phoniatrics and The Japan Laryngological Association. The 2018 recommendations, based on a review of the scientific literature, are intended to serve as clinical practice guidelines for the diagnosis, management, and treatment of voice disorders in Japan. METHODS: A summary of the original version of the Clinical Practice Guideline of Voice Disorders for Diagnosis, Management, and Treatment in Japan was described. Recommendations for the diagnosis, management, and treatment of voice disorders were prepared. Twelve clinical questions (CQs) regarding the diagnosis, management, treatment, and effectiveness of therapy for voice disorders were also prepared. RESULTS: A summary of the first version of the clinical practice guidelines for the diagnosis, management, and therapy of voice disorders was prepared and is presented. Additionally, answers to the 12 CQs on the diagnosis, management, treatment, and effectiveness of voice disorder therapy were prepared, and include evidence-based recommendations. CONCLUSION: These guidelines present a summary of the standard approaches for the diagnosis and treatment of voice disorders and relevant CQs that consider the medical environments in Japan. We hope that the guidelines will assist physicians in clinical settings for patients with voice disorders.